Holen Sie sich die Stockscreener-App
20.06
0.69%
-0.14
Handel nachbörslich:
20.06
Schlusskurs vom Vortag:
$20.20
Offen:
$20.23
24-Stunden-Volumen:
306.85K
Relative Volume:
1.09
Marktkapitalisierung:
$759.72M
Einnahmen:
$89.06M
Nettoeinkommen (Verlust:
$-53.41M
KGV:
-13.73
EPS:
-1.4612
Netto-Cashflow:
$-42.48M
1W Leistung:
-1.04%
1M Leistung:
+10.52%
6M Leistung:
+60.22%
1J Leistung:
+25.61%
1-Tages-Spanne:
$20.00
$20.47
1-Wochen-Bereich:
$19.69
$20.93
52-Wochen-Spanne:
$10.85
$24.33
Ceribell Inc Stock (CBLL) Company Profile
Firmenname
Ceribell Inc
Sektor
Branche
Telefon
(800) 436-0826
Adresse
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
20.06 | 765.02M | 89.06M | -53.41M | -42.48M | -1.4612 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2025-06-24 | Eingeleitet | BTIG Research | Buy |
| 2025-04-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-11-05 | Eingeleitet | BofA Securities | Buy |
| 2024-11-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-11-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-05 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ceribell Inc Aktie (CBLL) Neueste Nachrichten
Ceribell, Inc. (CBLL) reports Q1 loss, beats revenue estimates - MSN
Ceribell’s Earnings Call Signals Growth Over Profits - TipRanks
Earnings call transcript: Ceribell Inc. Q1 2026 misses EPS, revenue up - Investing.com
CeriBell (CBLL) Q1 2026 Earnings Transcript - The Globe and Mail
CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
CeriBell Q1 Loss Widens, Revenue Rises; Lifts Full-Year Revenue Guidance - Moomoo
Ceribell Inc (NASDAQ:CBLL) Q1 Revenue Beats Estimates, Net Loss Widens, Full-Year Guidance Raised - ChartMill
CERIBELL ($CBLL) Releases Q1 2026 Earnings - Quiver Quantitative
Ceribell beats Q1 revenue estimates; lifts 2026 guidance - TradingView
(CBLL) CeriBell Now Expects 2026 Revenue Range $112M-$116M, vs. FactSet Est of $113.1M - marketscreener.com
Earnings Flash (CBLL) CeriBell Posts Q1 Per Share Loss $0.52, vs. FactSet Est of Loss $0.39 - marketscreener.com
Earnings Flash (CBLL) Ceribell, Inc. Reports Q1 Revenue $26.5M, vs. FactSet Est of $26.1M - marketscreener.com
Ceribell Reports First Quarter 2026 Financial Results - The Manila Times
Number of shareholders of CeriBell, Inc. – NASDAQ:CBLL - TradingView
[144] Ceribell, Inc. SEC Filing - Stock Titan
Ceribell CEO Chao Xingjuan sells $783,973 in stock - Investing.com
Ceribell CEO Chao Xingjuan sells $783,973 in stock By Investing.com - Investing.com UK
Ceribell (NASDAQ: CBLL) CEO sells 39,000 shares after options exercise - Stock Titan
FMR LLC holds 4.85M CERIBELL shares (CBLL) — Amendment No.3 - Stock Titan
Earnings Preview: Ceribell to Report Financial Results Post-market on May 11 - Moomoo
Insider sells 78,000 CBLL shares and 2,084 more (CBLL) - Stock Titan
Ceribell CTO Raymond Woo sells $226,928 of CBLL common stock - Investing.com India
Ceribell CTO Raymond Woo sells $226,928 of CBLL common stock By Investing.com - Investing.com Australia
Ceribell (NASDAQ: CBLL) CTO sells shares under 10b5-1 trading plan - Stock Titan
Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference - 富途牛牛
CBLL (CBLL) Form 144 shows option-based sales and recent insider disposals - Stock Titan
CeriBell, Inc. (NASDAQ:CBLL) Sees Significant Decrease in Short Interest - MarketBeat
CeriBell (NASDAQ:CBLL) Stock Price Down 8.1%Should You Sell? - MarketBeat
Protara, Ceribell rise on FDA breakthrough designations - MSN
CeriBell, Inc.Common Stock (Nasdaq:CBLL) Stock Quote - FinancialContent
CeriBell a new buy at BTIG on growth in EEG monitoring system - MSN
CBLL Price Today: CeriBell, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
CBLL (CeriBell) reports narrower Q4 2025 loss than expected, as shares dip 0.85% in daily trading.Earnings Forecast - Cổng thông tin điện tử tỉnh Lào Cai
CeriBell (CBLL) Future Plans | CeriBell Inc. beats EPS estimates by 14.4% on narrower lossReceivables Turnover - Cổng thông tin điện tử tỉnh Tây Ninh
CeriBell (CBLL) Stock Interest Rate (+2.41%) 2026-04-22Alpha Picks - UBND thành phố Hải Phòng
CeriBell, Inc. (NASDAQ:CBLL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026 - The Manila Times
Ceribell, Inc. ($CBLL) President, CEO, and Co-Founder 2025 Pay Revealed | CBLL Stock News - Quiver Quantitative
Ceribell sets May 11 investor call for first-quarter results - Stock Titan
Press Release: Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026 - Moomoo
Ceribell | ARS: Annual Report to Security Holders - Moomoo
CeriBell (CBLL) Stock: Price Structure Insight (-0.52%) 2026-04-20Cycle Analysis - Cổng thông tin điện tử tỉnh Lào Cai
[ARS] Ceribell, Inc. SEC Filing - Stock Titan
CeriBell (NASDAQ: CBLL) details 2026 virtual meeting, board votes and pay - Stock Titan
Ceribell, Inc. unveils AI-powered EEG platform for neurologists at AAN2026 - Traders Union
Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL), ANI Pharmaceuticals (ANIP) and Amylyx Pharmaceuticals Inc (AMLX) - The Globe and Mail
CeriBell, Inc. (CBLL) Stock Analysis: Analysts See 32.94% Upside Potential In Innovative Medical Technology - DirectorsTalk Interviews
CCORF Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $28 - 富途牛牛
Ceribell Targets ICU Delirium With New EEG Study, Signaling Wider Market Ambitions - TipRanks
Finanzdaten der Ceribell Inc-Aktie (CBLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):